James Arthur Bristol, Director at Deciphera Pharmaceuticals, Inc. (DCPH), sold 17,782 shares at $28.04 ($499K) on 2019-02-15, disclosed to the SEC on 2019-02-19.
Open-market sale of $499k DCPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DCPH | SELL | 2021-04-14 | $1.3M | — | Filing → |
| DCPH | SELL | 2021-01-20 | $352K | — | Filing → |
| DCPH | SELL | 2020-10-13 | $2.5M | — | Filing → |